Merck Singapore R&D Collab Looks To Get Peptides Into Cells
Merck & Co is tapping government scientific researchers in Singapore to help overcome some of the limitations of macrocyclic peptide therapeutics.
You may also be interested in...
Astellas inks agreement with Dyno Therapeutics for access to its CapsidMap platform for novel AAV vectors. Taiho takes option to Arcus TIGIT-targeted antibody candidates.
Join the Asia Pacific content team for a wide-ranging overview and analysis of recent developments across China, India, South Korea and Japan in the policy, regulatory, commercial and vaccines spaces over the past few months.